Search

Author/Creator Jones, G N

1. 413PDPhase I clinical and translational evaluation of AZD6738 in combination with durvalumab in patients (pts) with lung or head and neck carcinoma. (23rd October 2018)

Authors:
Krebs, M; Lopez, J; El-Khoueiry, A; Bang, Y-J; Postel-Vinay, S; Abidah, W; Im, S-A; Khoja, L T; Standifer, N; Jones, G N; Marco-Casanova, P; Frewer, P; Berges, A; Cheung, A; Stephens, C; Felicetti, B; Dean, E; Pierce, A; Hollingsworth, S
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. (4th April 2018)

Authors:
Cruz, C; Castroviejo-Bermejo, M; Gutiérrez-Enríquez, S; Llop-Guevara, A; Ibrahim, Y H; Gris-Oliver, A; Bonache, S; Morancho, B; Bruna, A; Rueda, O M; Lai, Z; Polanska, U M; Jones, G N; Kristel, P; de Bustos, L; Guzman, M; Rodríguez, O; Grueso, J; Montalban, G; Caratú, G
Journal:
Annals of oncology
Issue:
Volume 29:Number 5(2018)
Page Start:
1203
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search